Partnership with TetraGenetics targets Type 1 diabetes
New partnership hopes to accelerate the development of a cure for Type 1 Diabetes.
New partnership hopes to accelerate the development of a cure for Type 1 Diabetes.
LifeArc has strengthened its board by appointing three new trustees.
(Blog first appeared on AMRC website on 4 December 2017. ) Mike Johnson, Executive Director, Business Development,…
A new platform for assessing anti-cancer drug efficacy could expedite the discovery of new cancer therapies.
The Royal Commission for the Exhibition of 1851 has awarded Industrial Fellowships worth up to £80,000 to…
Four therapies could lead to new treatments for desmoid tumours, neurofibromatosis, hereditary xerocystosis and post-traumatic stress disorder.
We have partnered with The Association of University Technology Managers (AUTM) Foundation to offer a competitive program that will provide essential training for scientists seeking a career in life sciences technology transfer.
Article in Nature Biotechnology about our new name and plans for the future (subscription needed to read…
We have launched the LifeArc Translational Award for academic scientists to progress early stage drug discovery projects.